Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mohamed Elsayed, Khaled T. Dardeer, Nimrat Khehra, Inderbir Padda, Heiko Graf, Amr Soliman, Abdelrahman M. Makram, René Zeiss & Carlos Schönfeldt-Lecuona. (2023) The potential association between psychiatric symptoms and the use of levonorgestrel intrauterine devices (LNG-IUDs): A systematic review. The World Journal of Biological Psychiatry 24:6, pages 457-475.
Read now
Read now
Gokce Turan, Pinar Yalcin Bahat, Berna Aslan Cetin & Nurullah Peker. (2021) The effect of a levonorgestrel-releasing intrauterine device on female sexual function. Journal of Obstetrics and Gynaecology 41:2, pages 269-274.
Read now
Read now
Sarah Rybowski & Pirjo Inki. (2011) Continuation rates and satisfaction with the Levonorgestrel Intrauterine System. Letter to the Editor in response to an article published in volume 31, by Dr. Ewies. Gynecological Endocrinology 27:5, pages 368-369.
Read now
Read now
Ayman A. A. Ewies. (2009) Levonorgestrel-releasing Intrauterine System – The discontinuing story. Gynecological Endocrinology 25:10, pages 668-673.
Read now
Read now
Articles from other publishers (16)
M.Y. Bongers, T Oderkerk, M Herman & P.M.A.J. Geomini. (2023) Nonsurgical treatment options for heavy menstrual bleeding. Facts, Views and Vision in ObGyn 15:Monograph, pages 17-23.
Crossref
Crossref
Elin Stenhammar, Per Wikman, Kristina Gemzell Danielsson, Helena Kopp-Kallner & Inger Sundström Poromaa. (2023) Levonorgestrel intrauterine device and depression: A Swedish register-based cohort study. International Journal of Psychophysiology 193, pages 112230.
Crossref
Crossref
Mei-An Middelkoop, Emma E Don, Wouter J K Hehenkamp, Nicole J Polman, Arjan W Griffioen & Judith A F Huirne. (2023) Angiogenesis in abnormal uterine bleeding: a narrative review. Human Reproduction Update 29:4, pages 457-485.
Crossref
Crossref
Jeffrey T. Jensen, Eeva Lukkari-Lax, Andrea Schulze, Yesmean Wahdan, Marco Serrani & Robin Kroll. (2022) Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial. American Journal of Obstetrics and Gynecology 227:6, pages 873.e1-873.e12.
Crossref
Crossref
Pleun Beelen, Marian J. van den Brink, Malou C. Herman, Peggy M.A.J. Geomini, Janny H. Dekker, Ruben G. Duijnhoven, Nienke Mak, Hannah S. van Meurs, Sjors F. Coppus, Jan Willem van der Steeg, Heleen P. Eising, Diana S. Massop-Helmink, Ellen R. Klinkert, Theodoor E. Nieboer, Anne Timmermans, Lucet F. van der Voet, Sebastiaan Veersema, Nicol A.C. Smeets, Joke M. Schutte, Marchien van Baal, Patrick M. Bossuyt, Ben Willem J. Mol, Marjolein Y. Berger & Marlies Y. Bongers. (2021) Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding. American Journal of Obstetrics and Gynecology 224:2, pages 187.e1-187.e10.
Crossref
Crossref
Agota Malmborg, Jan Brynhildsen & Mats Hammar. (2019) A survey of young women’s perceptions of the influence of the Levonorgestrel-Intrauterine System or copper-intrauterine device on sexual desire. Sexual & Reproductive Healthcare 21, pages 75-80.
Crossref
Crossref
Jim Slattery, Daniel Morales, Luis Pinheiro & Xavier Kurz. (2018) Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General Practice. Drug Safety 41:10, pages 951-958.
Crossref
Crossref
Mahyar Etminan, Hao Luo & Paul Gustafson. (2015) Risk of intracranial hypertension with intrauterine levonorgestrel. Therapeutic Advances in Drug Safety 6:3, pages 110-113.
Crossref
Crossref
Pierre Clerson, Olivier Graesslin, Adam Gater, Fiona Taylor, Anna Filonenko, Ilka Schellschmidt & Kimberly Rosen. (2014) EVAPIL-R Scale: Continuous Development and Validation of a Tool to Assess Patient-Reported Tolerability of Different Contraceptive Methods in Longitudinal Studies. Clinical Therapeutics 36:5, pages 638-647.e3.
Crossref
Crossref
David Kuzel, Lucie Hrazdirova, Kristyna Kubinova, Pavel Dundr, David Cibula & Michal Mara. (2013) Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system. Journal of Obstetrics and Gynaecology Research 39:5, pages 1014-1018.
Crossref
Crossref
Elena Toffol, Oskari Heikinheimo, Päivikki Koponen, Riitta Luoto & Timo Partonen. (2012) Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception 86:5, pages 470-480.
Crossref
Crossref
Sari Ahonkallio, Markku Santala, Hannu Valtonen & Hannu Martikainen. (2012) Cost-minimisation analysis of endometrial thermal ablation in a day case or outpatient setting under different anaesthesia regimens. European Journal of Obstetrics & Gynecology and Reproductive Biology 162:1, pages 102-104.
Crossref
Crossref
E. Toffol, O. Heikinheimo, P. Koponen, R. Luoto & T. Partonen. (2011) Hormonal contraception and mental health: results of a population-based study. Human Reproduction 26:11, pages 3085-3093.
Crossref
Crossref
M.N.G. Dukes. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
851
880
.
Hans Concin, Hubert Bösch, Peter Hintermüller, Thomas Hohlweg, Gerhard Mursch-Edlmayr, Bettina Pinnisch, Sigrid Schmidl-Amann, Gunda Schulz-Greinwald, Dagmar Unterlerchner, Teresa Wagner, Verena Mattle, Ludwig Wildt & Christian Fiala. (2009) Use of the levonorgestrel-releasing intrauterine system: an Austrian perspective. Current Opinion in Obstetrics & Gynecology 21:Suppl 1, pages S1-S9.
Crossref
Crossref
Douwe Arie A. Verkuyl. (2009) Intention-to-treat studies crucial for contraception research. Contraception 80:3, pages 234-236.
Crossref
Crossref